Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses

Current Biology

Volumn 14, Issue 19, 2004, Pages

  Coombes, Brian K ^a   Valdez, Yanet ^a   Finlay, B Brett ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BACTERIAL PROTEIN; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR;

BACTERIAL INFECTION; BACTERIUM; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; METABOLISM; PATHOGENICITY; PHAGOCYTOSIS; REVIEW; SECRETION; SIGNAL TRANSDUCTION;

ALPHA-DEFENSINS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; HUMANS; IMMUNITY, NATURAL; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS);

EID: 4644242673     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.09.043     Document Type: Review

References (115)

1. Janeway C.A. Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216
2. Medzhitov R., Janeway C.A. Jr. An ancient system of host defense. Curr. Opin. Immunol. 10:1998;12-15
3. Rosenberger C.M., Finlay B.B. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat. Rev. Mol. Cell Biol. 4:2003;385-396
4. Hornef M.W., Wick M.J., Rhen M., Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3:2002;1033-1040
5. Merrell D.S., Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature. 430:2004;250-256
6. Cornelis G.R., Van Gijsegem F. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:2000;735-774
7. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:1998;379-433
8. Cascales E., Christie P.J. The versatile bacterial type IV secretion systems. Nat. Rev. Microbiol. 1:2003;137-149
9. Nagai H., Roy C.R. Show me the substrates: modulation of host cell function by type IV secretion systems. Cell. Microbiol. 5:2003;373-383
10. Burns D.L. Biochemistry of type IV secretion. Curr. Opin. Microbiol. 2:1999;25-29
11. Sandkvist M. Type II secretion and pathogenesis. Infect. Immun. 69:2001;3523-3535
12. Desvaux M., Parham N.J., Henderson I.R. Type V protein secretion: simplicity gone awry? Curr. Issues Mol. Biol. 6:2004;111-124
13. Russel M. Macromolecular assembly and secretion across the bacterial cell envelope: type II protein secretion systems. J. Mol. Biol. 279:1998;485-499
14. Binet R., Letoffe S., Ghigo J.M., Delepelaire P., Wandersman C. Protein secretion by Gram-negative bacterial ABC exporters - a review. Gene. 192:1997;7-11
15. Henneke P., Golenbock D.T. Phagocytosis, innate immunity, and host-pathogen specificity. J. Exp. Med. 199:2004;1-4
16. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:2002;927-930
17. Celli J., Olivier M., Finlay B.B. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20:2001;1245-1258
18. Goehring U.M., Schmidt G., Pederson K.J., Aktories K., Barbieri J.T. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J. Biol. Chem. 274:1999;36369-36372
19. Cowell B.A., Chen D.Y., Frank D.W., Vallis A.J., Fleiszig S.M. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect. Immun. 68:2000;403-406
20. Garrity-Ryan L., Kazmierczak B., Kowal R., Comolli J., Hauser A., Engel J.N. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 68:2000;7100-7113
21. Persson C., Carballeira N., Wolf-Watz H., Fallman M. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 16:1997;2307-2318
22. Hamid N., Gustavsson A., Andersson K., McGee K., Persson C., Rudd C.E., Fallman M. YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb. Pathog. 27:1999;231-242
23. Shao F., Merritt P.M., Bao Z., Innes R.W., Dixon J.E. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell. 109:2002;575-588
24. Shao F., Golstein C., Ade J., Stoutemyer M., Dixon J.E., Innes R.W. Cleavage of Arabidopsis PBS1 by a bacterial type III effector. Science. 301:2003;1230-1233
25. Gruenheid S., Finlay B.B. Microbial pathogenesis and cytoskeletal function. Nature. 422:2003;775-781
26. Cossart P., Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science. 304:2004;242-248
27. Scott C.C., Botelho R.J., Grinstein S. Phagosome maturation: a few bugs in the system. J. Membr. Biol. 193:2003;137-152
28. Sinai A.P., Joiner K.A. Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu. Rev. Microbiol. 51:1997;415-462
29. Kagan J.C., Stein M.P., Pypaert M., Roy C.R. Legionella subvert the functions of rab1 and sec22b to create a replicative organelle. J. Exp. Med. 199:2004;1201-1211
30. Kagan J.C., Roy C.R. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat. Cell Biol. 4:2002;945-954
31. Nagai H., Kagan J.C., Zhu X., Kahn R.A., Roy C.R. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science. 295:2002;679-682
32. Celli J., de Chastellier C., Franchini D.M., Pizarro-Cerda J., Moreno E., Gorvel J.P. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:2003;545-556
33. Neild A.L., Roy C.R. Legionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation. Immunity. 18:2003;813-823
34. Houde M., Bertholet S., Gagnon E., Brunet S., Goyette G., Laplante A., Princiotta M.F., Thibault P., Sacks D., Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature. 425:2003;402-406
35. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 425:2003;397-402
36. Brumell J.H., Grinstein S. Salmonella redirects phagosomal maturation. Curr. Opin. Microbiol. 7:2004;78-84
37. Cosma C.L., Sherman D.R., Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57:2003;641-676
38. Hingley-Wilson S.M., Sambandamurthy V.K., Jacobs W.R. Jr. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat. Immunol. 4:2003;949-955
39. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science. 300:2003;1524-1525
40. Medzhitov R., Janeway C.A. Jr. Innate immune induction of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol. 64:1999;429-435
41. Mercurio F., Manning A.M. Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 11:1999;226-232
42. Israel A. The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10:2000;129-133
43. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 95:1998;588-593
44. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397
45. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983
46. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:2000;346-351
47. Zhang G., Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277:2002;7059-7065
48. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202
49. Netea M.G., Kullberg B.J., De Jong D.J., Franke B., Sprong T., Naber T.H., Drenth J.P., Van Der Meer J.W. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol. 34:2004;2052-2059
50. Hawn T.R., Verbon A., Lettinga K.D., Zhao L.P., Li S.S., Laws R.J., Skerrett S.J., Beutler B., Schroeder L., Nachman A., et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198:2003;1563-1572
51. Medvedev A.E., Lentschat A., Kuhns D.B., Blanco J.C., Salkowski C., Zhang S., Arditi M., Gallin J.I., Vogel S.N. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198:2003;521-531
52. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., Soudais C., Dupuis S., Feinberg J., Fieschi C., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 299:2003;2076-2079
53. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:2002;1958-1968
54. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:1999;811-815
55. Ernst R.K., Yi E.C., Guo L., Lim K.B., Burns J.L., Hackett M., Miller S.I. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science. 286:1999;1561-1565
56. Kawasaki K., Ernst R.K., Miller S.I. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J. Biol. Chem. 279:2004;20044-20048
57. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359
58. Blander J.M., Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science. 304:2004;1014-1018
59. Persson C., Nordfelth R., Andersson K., Forsberg A., Wolf-Watz H., Fallman M. Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism. Mol. Microbiol. 33:1999;828-838
60. Nakajima R., Motin V.L., Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63:1995;3021-3029
61. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168:2002;1315-1321
62. Yao T., Mecsas J., Healy J.I., Falkow S., Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J. Exp. Med. 190:1999;1343-1350
63. Nedialkov Y.A., Motin V.L., Brubaker R.R. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect. Immun. 65:1997;1196-1203
64. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71:2003;3673-3681
65. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., Aepfelbacher M., Heesemann J. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:2002;1017-1024
66. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hartung T., Adema G., Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172:2004;3712-3718
67. Girardin S.E., Philpott D.J. Mini-review: The role of peptidoglycan recognition in innate immunity. Eur. J. Immunol. 34:2004;1777-1782
68. Inohara N., Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:2003;371-382
69. O'Riordan M., Yi C.H., Gonzales R., Lee K.D., Portnoy D.A. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. USA. 99:2002;13861-13866
70. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., Bertin J., DiStefano P.S., Yaniv M., Sansonetti P.J., Philpott D.J. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:2001;736-742
71. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:2003;5509-5512
72. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:2003;8869-8872
73. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 300:2003;1584-1587
74. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:2003;702-707
75. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606
76. Opitz B., Puschel A., Schmeck B., Hocke A.C., Rosseau S., Hammerschmidt S., Schumann R.R., Suttorp N., Hippenstiel S. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279:2004;36426-36432
77. Kim J.G., Lee S.J., Kagnoff M.F. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun. 72:2004;1487-1495
78. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734
79. Tato C.M., Hunter C.A. Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect. Immun. 70:2002;3311-3317
80. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., Dixon J.E. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science. 285:1999;1920-1923
81. Orth K., Xu Z., Mudgett M.B., Bao Z.Q., Palmer L.E., Bliska J.B., Mangel W.F., Staskawicz B., Dixon J.E. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 290:2000;1594-1597
82. Hardt W.D., Galan J.E. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc. Natl. Acad. Sci. USA. 94:1997;9887-9892
83. Collier-Hyams L.S., Zeng H., Sun J., Tomlinson A.D., Bao Z.Q., Chen H., Madara J.L., Orth K., Neish A.S. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J. Immunol. 169:2002;2846-2850
84. Mahony J.B., Coombes B.K., Chernesky M.A. Chlamydia and Chlamydophila. Murray P.R. Manual of Clinical Microbiology. 2003;991-1004 ASM Press, USA
85. Starnbach M.N., Loomis W.P., Ovendale P., Regan D., Hess B., Alderson M.R., Fling S.P. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J. Immunol. 171:2003;4742-4749
86. Fling S.P., Sutherland R.A., Steele L.N., Hess B., D'Orazio S.E., Maisonneuve J., Lampe M.F., Probst P., Starnbach M.N. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA. 98:2001;1160-1165
87. Fan P., Dong F., Huang Y., Zhong G. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression. Infect. Immun. 70:2002;345-349
88. Zhong G., Liu L., Fan T., Fan P., Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J. Exp. Med. 191:2000;1525-1534
89. Zhong G., Fan T., Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1999;1931-1938
90. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 284:1999;1328-1333
91. Molinari M., Salio M., Galli C., Norais N., Rappuoli R., Lanzavecchia A., Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187:1998;135-140
92. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 301:2003;1099-1102
93. Boncristiano M., Paccani S.R., Barone S., Ulivieri C., Patrussi L., Ilver D., Amedei A., D'Elios M.M., Telford J.L., Baldari C.T. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198:2003;1887-1897
94. Zasloff M. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347:2002;1199-1200
95. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395
96. Ayabe T., Ashida T., Kohgo Y., Kono T. The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol. 12:2004;394-398
97. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 422:2003;522-526
98. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 286:1999;525-528
99. Chertov O., Yang D., Howard O.M., Oppenheim J.J. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol. Rev. 177:2000;68-78
100. Tani K., Murphy W.J., Chertov O., Salcedo R., Koh C.Y., Utsunomiya I., Funakoshi S., Asai O., Herrmann S.H., Wang J.M., et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int. Immunol. 12:2000;691-700
101. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7:2001;180-185
102. Salzman N.H., Chou M.M., de Jong H., Liu L., Porter E.M., Paterson Y. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 71:2003;1109-1115
103. Jin T., Bokarewa M., Foster T., Mitchell J., Higgins J., Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172:2004;1169-1176
104. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., Madara J.L. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 289:2000;1560-1563
105. Perrin A.J., Jiang X., Birmingham C.L., So N.S., Brumell J.H. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr. Biol. 14:2004;806-811
106. O'Riordan M., Portnoy D.A. The host cytosol: front-line or home front? Trends Microbiol. 10:2002;361-364
107. Brumell J.H., Tang P., Zaharik M.L., Finlay B.B. Disruption of the Salmonella-containing vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the cytosol of epithelial cells. Infect. Immun. 70:2002;3264-3270
108. Beuzon C.R., Salcedo S.P., Holden D.W. Growth and killing of a Salmonella enterica serovar Typhimurium sifA mutant strain in the cytosol of different host cell lines. Microbiology. 148:2002;2705-2715
109. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., Boquet P. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 387:1997;729-733
110. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 387:1997;725-729
111. Doye A., Mettouchi A., Bossis G., Clement R., Buisson-Touati C., Flatau G., Gagnoux L., Piechaczyk M., Boquet P., Lemichez E. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell. 111:2002;553-564
112. Munro P., Flatau G., Doye A., Boyer L., Oregioni O., Mege J.L., Landraud L., Lemichez E. Activation and proteasomal degradation of Rho GTPases by CNF1 elicit a controlled inflammatory response. J. Biol. Chem. 279:2004;35849-35857
113. Feng P., Scott C.W., Cho N.H., Nakamura H., Chung Y.H., Monteiro M.J., Jung J.U. Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol. Cell Biol. 24:2004;3938-3948
114. Kim J.H., Kang S., Kim J., Ahn B.Y. Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J. Virol. 77:2003;7166-7173
115. Finlay B.B., Hancock R.E. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2:2004;497-504